Atlas Trials

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

Clinical trial NCT01442376 · COMPLETED

Trial details

NCT number
NCT01442376
Sponsor
Helsinn Healthcare SA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chemotherapy-Induced Nausea and Vomiting
Start date
2011-09-01
Primary completion
2012-10-01
Enrollment
502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.